Mesa Laboratories (MLAB) Cash & Equivalents (2010 - 2025)

Mesa Laboratories (MLAB) has 16 years of Cash & Equivalents data on file, last reported at $29.0 million in Q4 2025.

• Quarterly Cash & Equivalents rose 6.05% year-over-year to $29.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.0 million (up 6.05% YoY) and the FY2025 annual result came in at $27.3 million, down 3.17% from the prior year.
• Cash & Equivalents advanced to $29.0 million in Q4 2025 per MLAB's latest filing, from $20.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $278.3 million in Q3 2021, with the low at $20.4 million in Q3 2025.
• Average Cash & Equivalents over 5 years is $67.8 million, with a median of $30.7 million recorded in 2023.
• Year-over-year, Cash & Equivalents jumped 224.24% in 2021 and plunged 88.37% in 2022.
• Mesa Laboratories' Cash & Equivalents stood at $51.7 million in 2021, then slumped by 49.52% to $26.1 million in 2022, then rose by 8.13% to $28.2 million in 2023, then decreased by 3.2% to $27.3 million in 2024, then rose by 6.05% to $29.0 million in 2025.
• Business Quant data shows MLAB's Cash & Equivalents at $29.0 million in Q4 2025, $20.4 million in Q3 2025, and $21.3 million in Q2 2025.